News / Press Release
| Displaying 1 to 10 of 84 | Previous 1 2 3 4 5 Next 10 |
February 22, 2010
BioDiscovery Releases a Unique New Global Repository for Genomic Variation Data
BioDiscovery, Inc. a leader in integrated software solutions for microarray-based research, announced today the release of Nexus DB a unique new repository for storing, querying, and sharing of genomic variation data from its popular Nexus Copy Number software.
February 10, 2010
BioDiscovery Releases Nexus Copy Number Version 5.0 for DNA Copy Number Analysis and Visualization
BioDiscovery, Inc. a leader in integrated software solutions for microarray-based research, announced today the release of version 5 of its popular Nexus Copy Number software, the leading platform independent and user friendly application for DNA copy number analysis of microarray derived data.
December 7, 2009
Cancer Centers Renew and Expand BioDiscovery’s Nexus Copy Number Software Licenses
BioDiscovery, Inc. a global leader in integrated software solutions for microarray-based research, announced today a number of license renewals and expansions of its Nexus Copy Number product at leading cancer research centers.
May 14, 2009
BioDiscovery Relocates Corporate Office
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, has relocated its corporate office to a new location within El Segundo, CA.
April 1, 2009
BioDiscovery Releases Nexus Copy Number Version 4 for DNA Copy Number Analysis and Visualization
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of Nexus Copy Number Version 4, a platform independent and efficient application for DNA copy number analysis of microarray derived data.
February 2, 2009
Fox Chase Cancer Center’s Keystone Program in Blood Cell Development and Cancer adopts Nexus Copy Number and Nexus Expression
BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research announced today that Fox Chase Cancer Center’s Keystone Program in Blood Cell Development and Cancer has acquired a site license for Nexus Copy Number and Nexus Expression, two companion tools designed specifically for scientists working on DNA copy number and RNA expression analysis from microarray data.
October 27, 2008
Johns Hopkins Medical Institute acquires BioDiscovery’s Nexus Expression software for analysis of gene regulation
BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research announced today that the Johns Hopkins Medical Institute has acquired a multi-seat license of Nexus Expression, a new intuitive and powerful tool for microarray gene expression analysis.
October 14, 2008
BioDiscovery Releases Nexus Expression – A Fresh Approach to Gene Regulation Analysis
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of Nexus Expression for gene expression analysis.
September 12, 2008
M. D. Anderson Cancer Center Expands its Site-License for BioDiscovery’s Nexus Copy Number Software
BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research announced today that M. D. Anderson Cancer Center in Houston, TX has expanded its site-license for Nexus Copy Number, an intuitive tool designed specifically for scientists to efficiently analyze and visualize chromosomal aberrations from microarray data.
June 3, 2008
Roche NimbleGen and BioDiscovery Form Strategic Alliance to Enhance CGH Microarrays, Software and Service
Roche NimbleGen Inc., a company of Roche Applied Science, announced today that it has formed a strategic alliance with BioDiscovery, Inc. to offer complete solutions to comparative genomic hybridization (CGH) microarray customers. The new high-density 2.1 million probe (HD2) arrays of Roche NimbleGen combined with industry-leading proprietary software, Nexus Copy Number, of BioDiscovery bring unprecedented power and ease in whole-genome CGH analysis.